Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.740
-0.030 (-1.69%)
At close: Dec 5, 2025, 4:00 PM EST
1.740
0.00 (-0.02%)
After-hours: Dec 5, 2025, 7:34 PM EST
Tiziana Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 12.58 | 10.57 | 9.87 | 1.63 | 14.17 | 24.42 | |
| Research & Development | 5.9 | 5.23 | 8.11 | 12.96 | 13.21 | 5.99 | |
| Operating Expenses | 18.47 | 15.79 | 17.98 | 14.59 | 27.37 | 30.41 | |
| Operating Income | -18.47 | -15.79 | -17.98 | -14.59 | -27.37 | -30.41 | |
| Interest Expense | - | - | -0.01 | -0.01 | -0.18 | -0.32 | |
| Interest & Investment Income | 0.71 | 0.81 | 1.15 | 0.03 | - | 0.01 | |
| Other Non Operating Income (Expenses) | 0.52 | - | - | 0.03 | 0.89 | - | |
| EBT Excluding Unusual Items | -17.25 | -14.98 | -16.84 | -14.53 | -26.66 | -30.72 | |
| Gain (Loss) on Sale of Investments | 2.85 | -1.77 | -0.4 | -0.87 | - | - | |
| Gain (Loss) on Sale of Assets | - | - | - | - | - | 2.66 | |
| Asset Writedown | - | - | - | - | - | -0.28 | |
| Pretax Income | -14.4 | -16.75 | -17.24 | -15.4 | -26.66 | -28.34 | |
| Income Tax Expense | -1.56 | -4.88 | 0.45 | - | -3.24 | -2.21 | |
| Net Income | -12.84 | -11.86 | -17.69 | -15.4 | -23.42 | -26.13 | |
| Net Income to Common | -12.84 | -11.86 | -17.69 | -15.4 | -23.42 | -26.13 | |
| Shares Outstanding (Basic) | 114 | 107 | 102 | 102 | 98 | 97 | |
| Shares Outstanding (Diluted) | 114 | 107 | 102 | 102 | 98 | 97 | |
| Shares Change (YoY) | 10.35% | 4.10% | 0.93% | 3.67% | 0.64% | - | |
| EPS (Basic) | -0.11 | -0.11 | -0.17 | -0.15 | -0.24 | -0.27 | |
| EPS (Diluted) | -0.11 | -0.11 | -0.17 | -0.15 | -0.24 | -0.27 | |
| Free Cash Flow | -8.76 | -1.55 | -15.7 | -19.62 | -21.78 | -11.34 | |
| Free Cash Flow Per Share | -0.08 | -0.01 | -0.15 | -0.19 | -0.22 | -0.12 | |
| EBITDA | -18.46 | -15.78 | -17.98 | -14.59 | -27.37 | -30.41 | |
| D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0 | 0.01 | 0.01 | |
| EBIT | -18.47 | -15.79 | -17.98 | -14.59 | -27.37 | -30.41 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.